)
Edge23 Jan 2026
Death, Taxes, and Garbage: The Story of WM
How Waste Management turned garbage into one of America's most stable business models through landfills, regulation, and nationwide scale.
Avinger
Avinger (AVGR) investor relations material
Avinger has been delisted
Avinger Q3 2024 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q3 2024 earnings summary7 Nov, 2024
Executive summary
Q3 2024 revenue ranged from $1.65 million to $1.7 million, with gross margin improving to 26% from 21% in Q3 2023 and net loss at $3.7 million, reflecting cost reduction measures including a 24% workforce reduction and sales realignment.
Operating efficiency improved, with a 15% reduction in net loss and 12% improvement in adjusted EBITDA compared to Q2 2024.
Pantheris LV launched commercially with strong early feedback, and the coronary CTO system advanced toward FDA submission, with IDE filing anticipated in Q4 2024 and patient enrollment expected in H1 2025.
Partnership with Zylox-Tonbridge advanced for China market entry, manufacturing, and regulatory progress, with regulatory approval anticipated in the second half of 2025.
Substantial doubt exists about the ability to continue as a going concern without additional financing, as cash is expected to fund operations only through Q4 2024.
Financial highlights
Q3 2024 revenue was $1.65–$1.7 million, down from $1.8 million in Q2 2024 and Q3 2023; nine-month revenue was $5.36 million, down 7% year-over-year.
Gross margin improved to 26% in Q3 2024 from 20% in Q2 2024 and 21% in Q3 2023; nine-month gross margin declined to 21% from 28% year-over-year.
Operating expenses declined to $4.1 million from $4.5 million in Q2 2024 and $4.4 million in Q3 2023.
Net loss was $3.7 million in Q3 2024, a 15% improvement from Q2 2024 and 17% from Q3 2023; nine-month net loss was $13.6 million.
Cash and cash equivalents totaled $5.9 million as of September 30, 2024, expected to fund operations only through Q4 2024.
Outlook and guidance
IDE application for the coronary CTO crossing system expected to be filed after FDA pre-submission feedback in Q4 2024, with patient enrollment targeted for H1 2025.
Regulatory approval for product entry into China anticipated in the second half of 2025, with manufacturing scale-up by Zylox-Tonbridge expected by mid-2025.
Cash on hand and expected revenues projected to fund operations only through Q4 2024; additional capital is needed to continue beyond this period.
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Avinger
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Avinger Inc. is a medical device company that develops and manufactures innovative catheter-based technologies for the treatment of peripheral artery disease (PAD). The company’s core products are image-guided, minimally invasive devices designed to help physicians diagnose and treat arterial blockages in the lower extremities. Avinger's proprietary technology, including its optical coherence tomography (OCT) imaging, enables real-time visualization of the artery during procedures, improving precision and outcomes for patients. The company focuses on advancing solutions that reduce the need for more invasive surgical interventions. The company is headquartered in Redwood City, California, and its shares are listed on the NASDAQ.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage